Exosens Stock Nears Resistance at €65.30 Following Bernstein's Upgrade
Exosens stock is up 2.2% this Wednesday at midday, trading at €65.00. This increase follows a significant target price upgrade by Bernstein. Over three months, the stock has recorded a performance of 47.23%, confirming a strong upward trend.
Bernstein Raises Target Price on Exosens
The American bank Bernstein raised its target price on Exosens from €61.00 to €72.50 on Monday, while maintaining its outperformance recommendation. At the current price of €65.00, this new target represents an approximate 11.5% upside potential. This upgrade is a signal of confidence in the trajectory of the optoelectronic technology specialist, whose stock has more than doubled over the past year with an increase of 108.9%. Exosens will publish its first quarter 2026 results on April 27, a milestone that will allow for a comparison of this valuation with the group's recent fundamentals.
Technical Analysis of Exosens Stock
From a technical perspective, the stock is currently at the immediate threshold of its resistance level at €65.30. A confirmed breach of this level could potentially open a new trading plateau. The price is now well above its 50-day moving average (€54.94), illustrating the recent acceleration of the buying trend over the past weeks. However, an RSI at 71 indicates that the stock is entering an overbought zone, meaning that the rise has been rapid enough that the risk of a technical consolidation increases. This situation does not invalidate the underlying trend, but it does call for caution in the short term. The upper Bollinger band, close to €65.60, confirms that the price is flirting with the extremes of its recent fluctuation range. The simultaneous approach to the resistance and this upper limit could temporarily slow down progress if trading volume does not follow.
